Femtosecond sub-Bowmen keratomileusis at the peak of the action of Botulinum toxin A, introduced into extraocular muscles in a patient with nystagmus: A clinical case
https://doi.org/10.21516/2072-0076-2019-12-2-69-72
Abstract
A clinical case of excimer laser correction performed by sub-Bowman femtosecond keratomileusis at the peak of botulinum toxin A effect in a patient with high congenital anisometropic myopia and horizontal nystagmus is presented. Keratorefractive surgery improved functional visual performance and the parameters of nystagmus.
About the Authors
N. V. Khodzhabekyan
Moscow Helmholtz Research Institute of Eye Diseases
Russian Federation
Russian Federation
Cand. Med. Sci., leading researcher, department of refraction pathology, binocular vision and ophthalmoergonomics
14/19, Sadovaya-Chernogryazskaya st., Moscow, 105062
A. V. Apaev
Moscow Helmholtz Research Institute of Eye Diseases
Russian Federation
Russian Federation
researcher, department of refraction pathology, binocular vision and ophthalmoergonomics
14/19, Sadovaya-Chernogryazskaya st., Moscow, 105062
A. T. Khandzhyan
Moscow Helmholtz Research Institute of Eye Diseases
Russian Federation
Russian Federation
Cand. Med. Sci., senior researcher, department of retinal and optic nerve pathology
14/19, Sadovaya-Chernogryazskaya st., Moscow, 105062
References
1. Avetisov E.S. Nystagmus. Moscow: GEOTAR-Media; 2001 (in Russian).
2. Theodorou M., Clement R. Classification of infantile nystagmus waveforms. Vision Research. 2016; 123: 20–5. http://dx.doi.org/10.1016/j.visres.2015.10.017
3. Crone R.A., De Jong P.T.V.M., Notermans G. Behandlung des Nystagmus durch Injektion von Botulinustoxin in die Augenmuskeln. Kiln. Mbl. Augenhelik. 1984; 184: 216–7.
4. Efimova E.L. The application of type A botulinum toxin for the treatment of patients presenting with various forms of strabismus. Russian Pediatric Ophthalmology. 2017; 12 (3): 153–62 (in Russian). doi http://dx.doi.org/10.18821/1993-1859-2017-12-3
5. Lennerstrand G., Nordbø O.A., Tian S., Eriksson-Derouet B., Ali T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998; 76 (1 Feb.): 27–7.
6. Mahler O., Hirsh A., Kremer I., et al. Laser in situ keratomileusis in myopic patients with congenital nystagmus. Journal of Cataract Refractive Surgery. 2006; 32: 464–7. doi: 10.1016/j.jcrs.2005.12.079
7. Tsiklis N.S., Kymionis G.D., Kounis G.A., et al. One-year results of photorefractive keratectomy and laser in situ keratomileusis for myopia using a 213 nm wavelength solid – state laser. Journal of Cataract Refractive Surgery. 2007; 33: 971–7. doi:10.1016/j.jcrs.2007.02.033
8. Plisov I.L., Kostenev S.V. Method of refraction anomalies corrections in patients with nystagmus. Patent RU # 2440082; 2012 (in Russian).
9. Jankovic J. Botuilinum toxin in movement disorders. Curr. Opin. Neurology. 1994; 7: 358–66.
10. Tarutta E.P., Gubkina G.L., Kantarzhi E.P., et al. Method of the estimation of optical nystagmus treatment effectiveness using microperimetry. Patent RU # 2535511; 2014 (in Russian).
Review
For citations:
Khodzhabekyan N.V., Apaev A.V., Khandzhyan A.T. Femtosecond sub-Bowmen keratomileusis at the peak of the action of Botulinum toxin A, introduced into extraocular muscles in a patient with nystagmus: A clinical case. Russian Ophthalmological Journal. 2019;12(2):69-72. (In Russ.) https://doi.org/10.21516/2072-0076-2019-12-2-69-72
Views:
777
Email this article 